Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is N/A as of Tuesday, October 6, 2026.
ENTERPRISE VALUE (EV)
N/A
Vogenx Inc.
Market Cap
$227.91M
Enterprise Value (EV)
N/A
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Vogenx Inc. (VOGX) | $227.91M | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $225.88M | $240.53M |
| Biodesix, Inc. (BDSX)vs › | $227.60M | $269.40M |
| Profound Medical Corp. (PROF)vs › | $220.93M | $189.92M |
| InflaRx N.V. (IFRX)vs › | $231.25M | $64.86M |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.62M | $222.75M |
| MacroGenics, Inc. (MGNX)vs › | $231.69M | $152.87M |
| Keros Therapeutics, Inc. (KROS)vs › | $217.50M | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $234.80M | $117.65M |
| Utah Medical Products, Inc. (UTMD)vs › | $235.30M | $235.49M |
Market Cap
$227.91M
Total Debt
N/A
Cash
N/A
Enterprise Value
N/A
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
